SMMA set about reimagining the interior office design — formerly home to a medical liability insurer, a completely different user type — focusing on innovation and alignment with Alnylam's brand and vision. The space had not undergone any significant renovation in twenty-plus years, so SMMA had to work within the confines of the base building shell. The client prioritized a design that encouraged employee collaboration while simultaneously accounting for individual needs.
Brand-Infused Design
Alnylam Pharmaceuticals is a developer of novel therapeutics based on RNA interference, a biopharmaceutical innovator based in one of the country’s most desirable office clusters for technology and innovation, Cambridge’s Kendall Square. The company engaged SMMA to lead an office interior design transformation, essentially revitalizing a two-star office space into one more commensurate with its five-star location.
The project necessitated a coordinated delivery approach to accommodate both a condensed schedule and the client’s rapid growth. SMMA’s integrated composition allowed its interior design team and MEP engineers to always be on the same page, working together and sharing ideas in pursuit of the optimal outcome.